The neuroprotective mechanism of dream via ERAD pathway In dyhydroxyphenylglycine preconditioned acute ischemic stroke rats / Nik Nasihah Nik Ramli

Neuroprotective strategies are required to complement the available medical treatments in order to enhance the brain endogenous protective mechanisms and cushion the effect of stroke injury. Pharmacological preconditioning is an avenue of preventative medication anticipated to be highly effective in...

Full description

Bibliographic Details
Main Author: Nik Ramli, Nik Nasihah
Format: Book Section
Language:English
Published: Institute of Graduate Studies, UiTM 2017
Subjects:
Online Access:https://ir.uitm.edu.my/id/eprint/19786/
_version_ 1848804852107313152
author Nik Ramli, Nik Nasihah
author_facet Nik Ramli, Nik Nasihah
author_sort Nik Ramli, Nik Nasihah
building UiTM Institutional Repository
collection Online Access
description Neuroprotective strategies are required to complement the available medical treatments in order to enhance the brain endogenous protective mechanisms and cushion the effect of stroke injury. Pharmacological preconditioning is an avenue of preventative medication anticipated to be highly effective in protecting and reducing the ischemic induced neuronal damage. Recently, in vitro preconditioning studies have shown that prior activation of group I metabotropic receptor (mGluR) with its specific agonist (S)- 3,5-dihydroxyphenylglycine ((S)-3,5-DHPG) elicits neuroprotection against excitotoxicity. Furthermore, the activation of group I mGluR regulates the expression of DREAM. DREAM protein regulates transcription of various genes including edem1 which is a component protein of ER-associated degradation pathway (ERAD). This study elucidates the neuroprotective effect of group I mGluR agonist preconditioning, (S)-3,5-DHPG via DREAM and ERAD in acute ischemic stroke rats. One, 10 or 100 μM (S)- 3,5-DHPG was administered intrathecally to 6 adult male Sprague Dawley rats 2 hours prior to the middle cerebral artery occlusion. After 24 hours, the modified neurological severity score (mNSS) and grid walking test were assessed. The rats were sacrificed and the infarct brain volumes were estimated by 2,3,5-triphenyltetrazolium chloride staining. The serum level of neuron-specific enolase (NSE) and brain tissue level of Bip/GRP78 ER stress marker were assessed by ELISA assays…
first_indexed 2025-11-14T22:01:43Z
format Book Section
id uitm-19786
institution Universiti Teknologi MARA
institution_category Local University
language English
last_indexed 2025-11-14T22:01:43Z
publishDate 2017
publisher Institute of Graduate Studies, UiTM
recordtype eprints
repository_type Digital Repository
spelling uitm-197862018-06-07T08:09:24Z https://ir.uitm.edu.my/id/eprint/19786/ The neuroprotective mechanism of dream via ERAD pathway In dyhydroxyphenylglycine preconditioned acute ischemic stroke rats / Nik Nasihah Nik Ramli Nik Ramli, Nik Nasihah Malaysia Neuroprotective strategies are required to complement the available medical treatments in order to enhance the brain endogenous protective mechanisms and cushion the effect of stroke injury. Pharmacological preconditioning is an avenue of preventative medication anticipated to be highly effective in protecting and reducing the ischemic induced neuronal damage. Recently, in vitro preconditioning studies have shown that prior activation of group I metabotropic receptor (mGluR) with its specific agonist (S)- 3,5-dihydroxyphenylglycine ((S)-3,5-DHPG) elicits neuroprotection against excitotoxicity. Furthermore, the activation of group I mGluR regulates the expression of DREAM. DREAM protein regulates transcription of various genes including edem1 which is a component protein of ER-associated degradation pathway (ERAD). This study elucidates the neuroprotective effect of group I mGluR agonist preconditioning, (S)-3,5-DHPG via DREAM and ERAD in acute ischemic stroke rats. One, 10 or 100 μM (S)- 3,5-DHPG was administered intrathecally to 6 adult male Sprague Dawley rats 2 hours prior to the middle cerebral artery occlusion. After 24 hours, the modified neurological severity score (mNSS) and grid walking test were assessed. The rats were sacrificed and the infarct brain volumes were estimated by 2,3,5-triphenyltetrazolium chloride staining. The serum level of neuron-specific enolase (NSE) and brain tissue level of Bip/GRP78 ER stress marker were assessed by ELISA assays… Institute of Graduate Studies, UiTM 2017 Book Section PeerReviewed text en https://ir.uitm.edu.my/id/eprint/19786/1/ABS_NIK%20NASIHAH%20NIK%20RAMLI%20TDRA%20VOL%2011%20IGS%2017.pdf Nik Ramli, Nik Nasihah (2017) The neuroprotective mechanism of dream via ERAD pathway In dyhydroxyphenylglycine preconditioned acute ischemic stroke rats / Nik Nasihah Nik Ramli. (2017) In: The Doctoral Research Abstracts. IGS Biannual Publication, 11 (11). Institute of Graduate Studies, UiTM, Shah Alam.
spellingShingle Malaysia
Nik Ramli, Nik Nasihah
The neuroprotective mechanism of dream via ERAD pathway In dyhydroxyphenylglycine preconditioned acute ischemic stroke rats / Nik Nasihah Nik Ramli
title The neuroprotective mechanism of dream via ERAD pathway In dyhydroxyphenylglycine preconditioned acute ischemic stroke rats / Nik Nasihah Nik Ramli
title_full The neuroprotective mechanism of dream via ERAD pathway In dyhydroxyphenylglycine preconditioned acute ischemic stroke rats / Nik Nasihah Nik Ramli
title_fullStr The neuroprotective mechanism of dream via ERAD pathway In dyhydroxyphenylglycine preconditioned acute ischemic stroke rats / Nik Nasihah Nik Ramli
title_full_unstemmed The neuroprotective mechanism of dream via ERAD pathway In dyhydroxyphenylglycine preconditioned acute ischemic stroke rats / Nik Nasihah Nik Ramli
title_short The neuroprotective mechanism of dream via ERAD pathway In dyhydroxyphenylglycine preconditioned acute ischemic stroke rats / Nik Nasihah Nik Ramli
title_sort neuroprotective mechanism of dream via erad pathway in dyhydroxyphenylglycine preconditioned acute ischemic stroke rats / nik nasihah nik ramli
topic Malaysia
url https://ir.uitm.edu.my/id/eprint/19786/